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Effect of Tong Qiao drops on the expression of eotaxin, IL-13 in the nasal
mucosa of rats with allergic rhinitis
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Received September 26, 2011; accepted May 10, 2012AbstractBackground: In recent years, particularly in China, many Chinese medicines and prescriptions for treating allergic rhinitis have been evaluated
for their clinical relevance. Studies have found that numerous herbs and their constituent compounds can significantly alleviate allergic
symptoms and are effective treatments for allergic rhinitis. The purpose of this study was to examine the modulatory effect of Tong Qiao nose
drops on allergy symptoms and the expression of cytokines in the nasal mucosa of rats with ovalbumin-induced allergic rhinitis.
Methods: Sixty healthy male Sprague Dawley rats were randomly divided into three groups (n ¼ 20): negative, control, and experimental. Rats in
the control or experimental groups were sensitized with ovalbumin to induce allergic rhinitis. The sensitized rats in the experimental group were
subsequently exposed to Tong Qiao nose drops, whereas the sensitized control rats were given saline nose drops. Negative control rats were only
treated with saline. Allergic symptoms and the pathologic features of the nasal mucosa were observed. The expression of eotaxin in the mucous
membrane of rat nasal septums was detected by immunohistochemical staining, and the expression levels of interleukin (IL)-5 and IL-13 were
measured by enzyme-linked immunosorbent assay.
Results: The symptom scores for the experimental group were significantly lower than those of control rats ( p < 0.01). Histopathologic
examination revealed pathologic changes of nasal mucosa edema in the experimental group was mild and the infiltration of eosinophils was
insubstantial. The expression levels of eotaxin, IL-5, and IL-13 in the nasal mucosa from experimental rats were significantly lower than that of
control rats ( p < 0.01).
Conclusion: Tong Qiao nose drops alleviated the symptoms of allergic rhinitis in a rat model and lowered the expression levels of eotaxin, IL-5,
and IL-13.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Allergic rhinitis (AR) is a type 1 immunoglobulin (Ig) E-
mediated hypersensitivity disease that is increasing in inci-
dence.1 In recent years, particularly in China, many Chinese
medicines and prescriptions for treating allergic rhinitis have
been evaluated for their clinical relevance. Studies have found
that numerous herbs and their constituent compounds can* Corresponding author. Dr. Shui-Hong Zhou, Department of Otolaryn-
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http://dx.doi.org/10.1016/j.jcma.2012.07.003significantly alleviate allergic symptoms and are effective
treatments for allergic rhinitis.2,3
Tong Qiao drops (Chengdu Huashen Zhiyao, Ltd Co.,
Chenddu, China), a new Chinese therapeutic formula that
contains active ingredients from three species of medicinal
plants: Angelica dahurica (Bai Zhi), Gleditsia sinensis Lam
(Zao Jia), and Flos Magnoliae (Xin Yi). Each agent of the
Tong Qiao drops has been demonstrated to have an anti-
iflammatory effect, and they can be used effectively to mini-
mize symptoms in many allergic diseases.4e6 However,
whether Tong Qiao drops have any demonstrable effect in the
treatment of allergic rhinitis has yet to be established. This
study sought to investigate the effect of Tong Qiao drops onhinese Medical Association. All rights reserved.
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anism of action. We used Tong Qiao nasal drops in rats with
ovalbumin-induced allergic rhinitis and measured its effect on
cytokine levels in the nasal mucosa.
2. Methods2.1. ReagentsTong Qiao nasal drops (10 g) A dahurica Bai Zhi, 1 g G
sinensis Lam Zao Jia, 10 gFMagnoliaeXin Yi, 80mL glycerol,
and sodium chloride were purchased from Chengdu Huasheng
Modern Biology Science & Technology Co (Chengdu, China).
Ovalbumin (OVA) was purchased from Sigma (St. Louis, MO,
USA), aluminum hydroxide gel (40 mg/mL) was purchased
from Gibco (Life Technologies Corp, Grand Island, NY, USA),
and rat interleukin (IL)-5 and IL-13 enzyme-linked immuno-
sorbent assay (ELISA) kitswere purchased fromShanghaiYi-Li
Bio-Technology Co., Ltd. (Shanghai, China). Rabbit antimouse
antieotaxin polyclonal antibody (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) and the ready-to-use EnVision reagent
(Dako Corporation, Copenhagen, Denmark) were also used.2.2. RatsInstitutional Review Board approval for the study was ob-
tained through our hospital. Eighty special pathogen free
(SPF) male Sprague Dawley (SD) rats, 6e8 weeks old and
weighing 180e220 g each, were housed in the First Affiliated
Hospital, Zhejiang University School of Medicine Laboratory
Animal Center. Using a random number table the rats were
divided into experimental, control, negative, and positive
control groups (n ¼ 20 per group).2.3. Induction of allergic rhinitis in ratsRats were sensitized following a revised version of the
protocol published by An et al.7 The sensitizing solution was
prepared by dissolving 0.3 mg OVA into 1 mL saline using
30mg aluminum hydroxide as an adjuvant (negative control rats
were given 1 mL saline plus 30 mg aluminum hydroxide). Rats
were injected intraperitoneally every other day for 14 days (for
a total of seven injections per rat). Starting on Day 14, the rats
were treated with 50 mL 2%OVA-saline solution in the form of
intranasal drops on each side of the nose, once a day for 7 days
(negative control rats were given saline drops). After the
development of allergic rhinitis (Day 21), experimental rats
were given Tong Qiao intranasal drops, two or three drops
(10 uL/kg/nostril) per treatment, three times per day for 7 or 15
days. Control rats were given saline nose drops. Positive control
rats were given mometasone furoate nasal spray was adminis-
tered topically at a volume of 10 mL into the bilateral nasal
cavities by micropipette 1 hour before the nasal antigen chal-
lenge (according to previous studies with modifications8,9).
Adhering to previous allergic rhinitis model scoring criteria,4
each animal was observed after nasal provocation for nose
scratching, sneezing, nasal discharge, and feeding behavior.Animal behavior was observed 30 minutes after the last nasal
provocation and was scored using the superposition and quantita-
tive method,4 in which a total score more than five points indicates
successful induction of allergic rhinitis. Symptoms were scored as
follows: nasal itch, 1¼ scratching the nose lightly one to two times,
2 ¼ scratching the nose and face constantly; sneeze, 1 ¼ one to
three times, 2 ¼ four to 10 times, 3 ¼ 11 or more times; nasal
discharge, 1¼ secretions flow to the anterior nostril, 2¼ secretions
surpass the anterior nostril, 3¼ secretions cover the face.2.4. Nasal mucosa tissue collectionFollowing 30 minutes after the last nasal provocation, all
animals were anesthetized with 1% pentobarbital sodium
(50 mg/kg body weight), which was administered by intra-
peritoneal injection. The nasal septum mucosa of each rat was
harvested, and a portion of each sample was fixed in 10%
formaldehyde. Additional portions of each sample were
immediately stored in liquid nitrogen for future use.2.5. Pathologic observationAfter fixing in formaldehyde, the nasal septum mucosa
specimens were embedded in paraffin, sliced into 4 mm-thick
sections, and then stained by hematoxylin and eosin. Samples
were observed under an optical microscope.2.6. Immunohistochemical staining for eotaxin in nasal
mucosaCryopreserved nasal mucosa tissue samples were thawed,
rehydrated, embedded in paraffin, and sliced into 4 mm-thick
sections. Samples were deparaffinized using a baking sheet and
water, washed with phosphate-buffered saline (PBS) for 3
minutes (two times), then subjected to two rounds of submersion
in 0.3% hydrogen peroxide for 10minutes, followed bywashing
in PBS for 3 minutes (two times) to block endogenous peroxi-
dase activity. Rabbit anti-mouse antieotaxin polyclonal anti-
body was added to the samples at a 1:100 dilution at 37C for 2
hours, followed by the addition of the ready-to-use EnVision
reagent. After incubation at 37C for 30 minutes, samples were
washed in PBS for 3 minutes (three times) before staining with
diaminobenzidine for 1e3 minutes, as well as hematoxylin.
Sections were dried, mounted with neutral resin, and observed
under an optical microscope. The nuclei stained blue, while
eotaxin staining appeared as yellow or brown granules in the
cytoplasm. Positive staining was defined visually, using the
semi-quantitative staining intensity method: negative (), not
stained or appeared as background; weakly positive (þ), few
small granules; strongly positive (þþþ), numerous coarse
granules; positive staining ranged between (þ) and (þþþ).2.7. Measurement of IL-5 and IL-13 in nasal mucosa
tissueApproximately 200 mg of nasal mucosa tissue was homog-
enized in saline solution on ice. Samples were centrifuged at
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The levels of IL-5 and IL-13 were measured in the supernatants
by ready-made ELISA kits, according to manufacturer
instructions. Plates were read at 490 nm using a microplate
reader (ELx808 Super microplate reader; Shanghai Bio-
Technology Co., Ltd. Shanghai, China). All specimens were
run simultaneously.2.8. Statistical analysisMeasurement data are expressed as the mean  standard
deviation (SD). Group differences of continuous variables
were compared by analysis of variance (ANOVA) using SPSS
16.0 for Windows (SPSS, Chicago, IL USA). A p value less
than 0.05 was considered statistically significant.
3. Results3.1. Allergic rhinitis symptomsIn the control group, 19 rats were sensitized with OVA and
presented with typical symptoms of allergic rhinitis which
included abundant, clear nasal discharge, frequent sneezing,
severe scratching, and gasping (Table 1). Of the experimental
rats, prior to treatment, 18 presentedwith typical allergic rhinitis
symptoms. Seven days after treatment, the total symptom scores
of allergic rhinitis in the negative, control, experimental, and
positive control group rats were 1.7, 22.0, 17.5, and 16.9,
respectively. The scores of the control group, experimental
group and positive control group were not significant different
( p > 0.05). Fifteen days after treatment, the total symptom
scores of allergic rhinitis in the negative, control, experimental,
and positive control group rats were 1.6, 22.0, 7.8, and 6.9,
respectively. The score of the control group was significantly
higher than the experimental group ( p < 0.01). The signs and
symptoms of the experimental group were significantly reduced
as compared with the control group ( p < 0.01), with mild
sneezing and nasal gasping movements. The signs and symp-
toms of the experimental group were not significant different as
compared with the positive control ( p > 0.05). Rats in the
negative group were asymptomatic.3.2. Histopathologic changesIn the control rats, nasal mucosa edema, vasodilation,
glandular hyperplasia, and eosinophil infiltration were seen in
the lamina propria (Fig. 1). In the experimental group and
positive control rats, the nasal mucosa edema was mild and theTable 1
Results of symptoms in different groups.
Group n Nose scratch Discharge
Negative 20 0.4  0.1 0.5  0.2
Control 19 5.0  1.36 2.5  0.66
Experimental 18 2.2  1.0* 0.9  0.3*
Positive control 20 2.0  0.9 0.8  0.3
6compared between control group and negative group, P < 0.01; *comparison binfiltration of eosinophils was insubstantial. In the negative
group, no mucosal edema or eosinophil infiltration was
observed.3.3. Eotaxin expression in the nasal mucosaUsing immunohistochemical staining, eotaxin was detected
within epithelial cells, glandular cells, fibroblasts, macro-
phages, endothelial cells, and other inflammatory cells
(Fig. 2). In the control group, eotaxin-positive cells were
detected around the epithelial cells and glandular cells of the
nasal mucosa; two rats were positive, and eight rats were
strongly positive. In the negative group, no significant eotaxin
staining was seen in the nasal mucosa, although eight rats had
weakly positive staining. In the experimental group, eotaxin-
positive cells were substantially reduced; one case was posi-
tive, and eight cases were weakly positive. In the positive
control group, eotaxin-positive cells were substantially
reduced; two cases were positive, and six cases were weakly
positive.3.4. Expression of IL-5 and IL-13 in the nasal mucosaThe levels of IL-5 in the nasal mucosa of the negative,
control, and experimental rats were 7.1  1.6 pg/mL,
13.4  1.9 pg/mL, and 8.2  1.0 pg/mL, respectively, whereas
the levels of IL-13 were 23.7  2.1 pg/mL, 33.6  2.9 pg/mL,
and 22.0  1.1 pg/mL, respectively (Table 2). After treatment
with Tong Qiao nasal drops, the levels of IL-5 and IL-13 in the
nasal mucosa of experimental rats were significantly lower
than in the control group. The difference was statistically
significant ( p < 0.01), though they were still lower compared
to the negative group, and were higher compared with the
positive control group where there was no statistical difference
at all ( p > 0.05).
4. Discussion
Allergic rhinitis is also referred to as “congested nose tears”
in traditional Chinese medicine. Its etiology and pathogenesis
is mainly ascribed to lung qi deficiency. In other words, body
fluid accumulates in the lungs and nasal passages congest, thus
causing sneezing and runny nose. The nose is considered the
open mouth of the lung, so nasal discharge originates in the
lung as a way to clear yang qi from the spleen and kidney.
Because nutrition is absorbed by the kidney, this disease is
considered related to spleen and kidney deficiencies. Often,
treatments target symptoms, while, according to traditionalSneeze Gasp Total score
0.3  0.1 0.4  0.1 1.6
13.0  2.96 1.5  0.56 22.0
4.3  1.5* 0.4  0.2* 7.8*
4.0  1.0 0.4  0.1 6.9
etween experimental group and control group.
Fig. 2. Eotaxin expression in nasal mucosa of rats with allergic rhinitis, with or without treatment. Nasal mucosa tissue (arrow) from (A) control (allergic rhinitis);
(B) negative (healthy); (C) experimental (allergic rhinitis treated with Tong Qiao drops); and (D) positive control (allergic rhinitis treated with mometasone furoate)
rats were subject to immunohistochemical staining for eotaxin (brown staining). Magnification, 200.
Fig. 1. Histopathological changes in allergic rhinitis with or without treatment. (A) In sensitized control rats, nasal mucosa edema, vasodilation, glandular
hyperplasia, and substantial eosinophil infiltration (arrow) were observed in the lamina propria; (B) negative control rats had no mucosal edema or eosinophil
infiltration (arrow); (C) after treatment with Tong Qiao drops, the nasal mucosa edema was less severe, with less eosinophil infiltration (arrow); (D) positive control
rats had less mucosal edema or eosinophil infiltration. Hematoxylin and eosin staining (arrow). Magnification, 200.
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Table 2
Expression of IL-5 and IL-13 in the rat nasal mucosa in different groups.
Group N IL-5 (pg/ml) IL-13 (pg/ml)
Negative 20 7.1  1.6 23.4  2.1
Control 19 13.4  1.96 33.6  2.886
Experimental 18 8.2  1.0* 22.0  1.1*
Positive control 20 7.5  0.8 20.2  0.7
6compared between control group and negative group, P < 0.01; *compar-
ison between experimental group and control group; IL ¼ interleukin.
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cold from the lungs to warm the yang.10 The use of Chinese
medicine can significantly reduce the financial burden of
patients and the state. Studies have shown that F magnoliae
has reliable anti-inflammatory effects for some acute and
chronic inflammatory diseases in animal models. For example,
it can significantly reduce congestion, edema, necrosis,
inflammatory cell infiltration, and other inflammatory reac-
tions, and can significantly suppress the adhesion of eosino-
phils, neutrophils, and vascular endothelial cells.11 A dahurica
and G sinensis Lam also have anti-inflammatory and anti-
allergic effects.3e6,11e14 Kung et al.4 suggested that adding
single herbal drugs into Chinese herbal formula in one
prescription could enhance the therapeutic effect or address
certain allergic rhinitis-related symptoms. In this study, we
analyzed the expression of eotaxin, IL-5, and IL-13 in the
nasal mucosa of rats with allergic rhinitis. F magnoliae, A
dahurica, and G sinensis Lam were incorporated into the Tong
Qiao nasal drops, which were used to treat the rats; we
observed the effect of these drops as a treatment for OVA-
induced allergic rhinitis.
To elucidate the mechanism of eotaxin, IL-5, and IL-13 in
the pathogenesis of allergic rhinitis, this study used OVA
sensitization to establish a rat model of allergic rhinitis. Our
results suggested that eotaxin, IL-5, and IL-13 are involved in
the pathogenesis of allergic rhinitis. Eotaxin is considered to
be an important eosinophil chemotactic factor.18 Azazi et al.15
found that eotaxin level was higher in the patients with allergic
rhinitis. Erin et al.16 found elevated levels of IL-3, IL-5, and
eotaxin in the nasal lavage of seasonal AR patients. Pagani
et al.17 also confirmed that IL-3, IL-5, and eotaxin might play
a role in the pathophysiology of allergies. They detected the
IL-3, IL-5, and eotaxin levels in the nasal lavage of AR
patients using the quantitative sandwich enzyme immunoassay
technique. They found that the IL-3, IL-5, and eotaxin levels
were statistically significant higher than those in the healthy
controls before treatment.17
This study determined that in OVA-induced allergic
rhinitis, treatment with Tong Qiao nasal drops lowered
symptom scores significantly as compared with no treatment,
and similar as compared to treatment with mometasone furo-
ate, a proven medicine for allergic rhinitis.18 Yet, despite this
result, symptom scores were still higher after treatment than in
the negative group, suggesting that Tong Qiao nasal drops can
relieve symptoms of allergic rhinitis, but they do not prevent
them. These experiments also showed that the number of
inflammatory cells that infiltrated the nasal mucosa aftertreatment with Tong Qiao nasal drops was less than without
treatment. Edema and hyperemia were also less severe upon
treatment and, in fact, were not significantly different as
compared with the negative control group. Therefore, we
demonstrated that Tong Qiao nasal drops may inhibit the
inflammatory response in the mucosa of rats with allergic
rhinitis, thus leading to a reduction in local allergic reactions.
In addition, Tong Qiao nasal drops significantly reduced the
expression of eotaxin, IL-5, and IL-13 in the nasal mucosa of
these rats as compared with untreated rats. Other studies have
demonstrated that some herbals may regulate endocrine-
immune system and can down-regulate the Th2 cells and
their cytokines IL-4 and IL-5,19 IL-6 and IL-13,20 and
eotaxin.21 Our data suggest that the antiallergic rhinitis
mechanism of Tong Qiao nasal drops involves the reduction of
eotaxin, IL-5, and IL-13 expression levels in the nasal mucosa
tissue as well as the inhibition of eosinophil infiltration.
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